WINDTREE THERAPEUTICS INC /DE/ Repayments of Short-term Debt
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Repayments of Short-term Debt of $166.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2025-05-15
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for the quarter ending 2025-03-31 was $166.00K, a 28.76% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for the quarter ending 2024-12-31 was $111.00K, a 52.56% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for the quarter ending 2024-09-30 was $111.00K, a 52.36% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for fiscal 2024 was $455.00K, a 42.91% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for fiscal 2023 was $797.00K, a 32.11% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for fiscal 2022 was $1.17M, a 69.68% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ repayments of short-term debt for fiscal 2021 was $3.87M, a 19.91% increase from fiscal 2020.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2025-03-31 | $166.00K 10-Q · filed 2025-05-15 | $277.00K derived: sum of 2 quarters · filed 2025-05-15 | $388.00K derived: sum of 3 quarters · filed 2025-05-15 | $388.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $222.00K derived: sum of 2 quarters · filed 2025-04-15 | $222.00K derived: sum of 3 quarters · filed 2025-04-15 | $455.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $111.00K derived: sum of 2 quarters · filed 2024-11-26 | $344.00K 10-Q · filed 2024-11-26 | $578.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $233.00K 10-Q · filed 2024-08-19 | $467.00K derived: sum of 3 quarters · filed 2025-05-15 | $700.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $233.00K 10-Q · filed 2025-05-15 | $467.00K derived: sum of 2 quarters · filed 2025-05-15 | $700.00K derived: sum of 3 quarters · filed 2025-05-15 | $778.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $467.00K derived: sum of 2 quarters · filed 2025-04-15 | $545.00K derived: sum of 3 quarters · filed 2025-04-15 | $797.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $311.00K derived: sum of 2 quarters · filed 2024-11-26 | $563.00K 10-Q · filed 2024-11-26 | $940.00K derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $330.00K 10-Q · filed 2024-08-19 | $707.00K derived: sum of 3 quarters · filed 2024-08-19 | $1.08M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $252.00K 10-Q · filed 2024-05-15 | $629.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.01M derived: sum of 3 quarters · filed 2024-05-15 | $1.13M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $755.00K derived: sum of 2 quarters · filed 2024-04-16 | $880.00K derived: sum of 3 quarters · filed 2024-04-16 | $1.17M 10-K · filed 2024-04-16 |
| 2022-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $503.00K derived: sum of 2 quarters · filed 2023-11-09 | $797.00K 10-Q · filed 2023-11-09 | $1.24M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $419.00K 10-Q · filed 2023-08-07 | $860.00K derived: sum of 3 quarters · filed 2023-08-07 | $1.30M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $294.00K 10-Q · filed 2023-05-15 | $735.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.18M derived: sum of 3 quarters · filed 2023-05-15 | $3.81M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $881.00K derived: sum of 2 quarters · filed 2023-03-31 | $3.52M derived: sum of 3 quarters · filed 2023-03-31 | $3.87M 10-K · filed 2023-03-31 |
| 2021-09-30 | $440.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.08M derived: sum of 2 quarters · filed 2022-11-14 | $3.43M 10-Q · filed 2022-11-14 | $3.78M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.99M 10-Q · filed 2022-08-11 | $3.34M derived: sum of 3 quarters · filed 2022-08-11 | $6.02M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $352.00K 10-Q · filed 2022-05-05 | $704.00K derived: sum of 2 quarters · filed 2022-05-05 | $3.38M derived: sum of 3 quarters · filed 2022-05-05 | $3.38M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.03M derived: sum of 2 quarters · filed 2022-03-31 | $3.03M derived: sum of 3 quarters · filed 2022-03-31 | $3.23M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.68M derived: sum of 2 quarters · filed 2021-11-10 | $2.88M 10-Q · filed 2021-11-10 | $4.12M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $199.00K 10-Q · filed 2021-08-05 | $1.44M derived: sum of 3 quarters · filed 2021-08-05 | $1.79M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $199.00K 10-Q · filed 2021-05-13 | $1.44M derived: sum of 2 quarters · filed 2021-05-13 | $1.79M derived: sum of 3 quarters · filed 2021-05-13 | $1.81M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.59M derived: sum of 2 quarters · filed 2021-03-29 | $1.62M derived: sum of 3 quarters · filed 2021-03-29 | $2.06M 10-K · filed 2021-03-29 |
| 2019-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $373.00K derived: sum of 2 quarters · filed 2020-11-16 | $820.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $474.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $447.00K 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $160.00K 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |